ATE216247T1 - Aromatische oligomere verbindungen als imitatoren bioaktives makromoleküle - Google Patents

Aromatische oligomere verbindungen als imitatoren bioaktives makromoleküle

Info

Publication number
ATE216247T1
ATE216247T1 AT92912715T AT92912715T ATE216247T1 AT E216247 T1 ATE216247 T1 AT E216247T1 AT 92912715 T AT92912715 T AT 92912715T AT 92912715 T AT92912715 T AT 92912715T AT E216247 T1 ATE216247 T1 AT E216247T1
Authority
AT
Austria
Prior art keywords
oligomeric compounds
disorders
immittators
treatment
bioactive macromolecules
Prior art date
Application number
AT92912715T
Other languages
English (en)
Inventor
John R Regan
Daniel G Mcgarry
Michael N Chang
Jeffrey N Barton
Jack Newman
Schmuel Ben-Sasson
Original Assignee
Rhone Poulenc Rorer Internat H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Internat H filed Critical Rhone Poulenc Rorer Internat H
Application granted granted Critical
Publication of ATE216247T1 publication Critical patent/ATE216247T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G8/00Condensation polymers of aldehydes or ketones with phenols only
    • C08G8/04Condensation polymers of aldehydes or ketones with phenols only of aldehydes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyamides (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
AT92912715T 1991-05-20 1992-05-20 Aromatische oligomere verbindungen als imitatoren bioaktives makromoleküle ATE216247T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70306191A 1991-05-20 1991-05-20
PCT/US1992/004274 WO1992020350A1 (en) 1991-05-20 1992-05-20 Aromatic oligomeric compounds useful as mimics of bioactive macromolecules

Publications (1)

Publication Number Publication Date
ATE216247T1 true ATE216247T1 (de) 2002-05-15

Family

ID=24823810

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92912715T ATE216247T1 (de) 1991-05-20 1992-05-20 Aromatische oligomere verbindungen als imitatoren bioaktives makromoleküle

Country Status (8)

Country Link
EP (1) EP0585371B1 (de)
AT (1) ATE216247T1 (de)
AU (1) AU2010792A (de)
DE (1) DE69232557T2 (de)
DK (1) DK0585371T3 (de)
ES (1) ES2174834T3 (de)
MX (1) MX9202389A (de)
WO (1) WO1992020350A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60139025D1 (de) 2000-12-28 2009-07-30 Takeda Pharmaceutical Alkansäurederivate, verfahren zu deren herstellung und deren verwendung
EP1394154A4 (de) 2001-03-23 2005-05-18 Takeda Pharmaceutical Fünfgliedriges heterocyclisches alkansäurederivat
WO2005026150A1 (en) 2003-09-16 2005-03-24 Astrazeneca Ab Quinazoline derivatives as tyrosine kinase inhibitors
US7709468B2 (en) 2005-09-02 2010-05-04 Abbott Laboratories Imidazo based heterocycles
AU2019234670B2 (en) 2018-03-13 2023-11-23 Takeda Pharmaceutical Company Limited Substituted imidazopyridines as inhibitors of plasma kallikrein and uses thereof
EP4477220A3 (de) 2019-09-18 2025-02-26 Takeda Pharmaceutical Company Limited Plasmakallikreinhemmer und verwendungen davon
EP4031245A1 (de) 2019-09-18 2022-07-27 Takeda Pharmaceutical Company Limited Heteroaryl-plasma-kallikrein-inhibitoren
WO2023166346A1 (en) 2022-03-02 2023-09-07 Horizon Therapeutics Ireland Dac Process of making a crystalline edg-2 receptor antagonist

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2323481A (en) * 1939-03-14 1943-07-06 Du Pont Chemical process and composition
US2910484A (en) * 1957-05-09 1959-10-27 Ciba Pharm Prod Inc Polyhydric-aldehyde condensation products
US4604404A (en) * 1985-04-03 1986-08-05 A. H. Robins Company, Inc. Antiviral sulfonated naphthalene formaldehyde condensation polymers
IL95353A (en) * 1989-08-14 1995-01-24 Rhone Poulenc Rorer Int Pharmaceutical preparations containing aromatic polymers
EP0502117B1 (de) * 1989-11-22 1999-06-23 Rhone-Poulenc Rorer International (Holdings) Inc. Pharmazeutische präparate enthaltend polymere mit alkyl- oder heteroalkylhauptketten
FR2672214A1 (fr) * 1991-01-31 1992-08-07 Rhone Poulenc Rorer Sa Application de polymeres biologiquement actifs, pour l'obtention d'un medicament pour le traitement d'infections a retrovirus.

Also Published As

Publication number Publication date
EP0585371A4 (en) 1994-07-13
EP0585371A1 (de) 1994-03-09
DE69232557D1 (de) 2002-05-23
EP0585371B1 (de) 2002-04-17
DE69232557T2 (de) 2002-10-24
WO1992020350A1 (en) 1992-11-26
ES2174834T3 (es) 2002-11-16
MX9202389A (es) 1993-08-01
AU2010792A (en) 1992-12-30
DK0585371T3 (da) 2002-08-12

Similar Documents

Publication Publication Date Title
DK1133989T3 (da) Polymersammensætning til anvendelse i terapi
IL225192A (en) Combinations of dextromethorphan and quinidine for the preparation of mental illness, neuropathic pain or brain injury
JO2373B1 (en) W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors
ATE298790T1 (de) Phosphatase oder ein entsprechendes derivat enthaltene pharmazeutische zusammensetzung
TW264480B (de)
ATE457166T1 (de) Orale zusammensetzungen zur behandlung von diabetes
SG147274A1 (en) Prevention and treatment of amyloidogenic disease
BRPI0509366B8 (pt) composição farmacêutica, kit farmacêutico, e, uso de uma composição farmacêutica
BRPI0211200B8 (pt) peptídeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células
PL342078A1 (en) Inhibition of raf kinase using symmetrical and dissymmetrical substituted dimethylureas
ATE350019T1 (de) Verfahren zur behandlung von kapseln und trockenen gepulverten pharmazeutischen formulierungen
ATE106737T1 (de) Pharmazeutische zusammensetzungen zur behandlung gastrointestinaler störungen.
ATE216247T1 (de) Aromatische oligomere verbindungen als imitatoren bioaktives makromoleküle
DE69429856D1 (de) Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit
WO1999056666A8 (en) The treatment of sexual dysfunction in certain patient groups
ATE255411T1 (de) Hyaluronsäurerezeptoren bindende stoffe und deren verwendung zur behandlung von tumoren und restenose
DE60004093D1 (de) Pharmazeutische zusammensetzung welche riluzol und gabapentin enthält zur behandung von motoneuronalen krankheiten
RU98114982A (ru) Состав, содержащий диосгенин
GR3020232T3 (en) LOW-MOLECULAR SULPHATED POLY--g(b)-2,6-FRUCTOFURANOSANES AND THEIR USE IN THE TREATMENT OF DEGENERATIVE ARTICULAR AILMENTS
BG105763A (en) Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee